ARDELYX, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
ARDELYX, INC. (ARDX) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $13.30 million as of 2020-12-31, per its 10-K filed 2021-03-08.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2021-03-08
- 2020-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $13.30M.
- 2019-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $13.20M.
- 2018-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $9.80M.
- 2017-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $8.60M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2020-12-31 | $13.30M 10-K · filed 2021-03-08 | |
| 2019-12-31 | $13.20M 10-K · filed 2021-03-08 | |
| 2018-12-31 | $9.80M 10-K · filed 2021-03-08 | |
| 2017-12-31 | $8.60M 10-K · filed 2020-03-06 | |
| 2016-12-31 | $3.50M 10-K · filed 2019-03-06 | $3.90M 10-K · filed 2017-02-17 |
| 2015-12-31 | $2.90M 10-K · filed 2018-03-14 | $3.30M 10-K · filed 2016-03-04 |
| 2014-12-31 | $2.80M 10-K · filed 2017-02-17 | |
| 2013-12-31 | $1.40M 10-K · filed 2016-03-04 | |
| 2012-12-31 | $1.10M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |